Company: SRPT
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0000950170-25-083131
Chunk: 0

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-06-06
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 5, 2025, Sarepta Therapeutics, Inc. (the “ Company”) held its annual meeting of stockholders (the “ Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted to approve Amendment No. 4 (the “2018 Plan Amendment”) to the Company’s 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan Amendment increases the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2018 Plan by 4,300,000 shares to 17,487,596 shares. The foregoing summary of the 2018 Plan Amendment is qualified in its entirety by reference to the full text of the 2018 Plan Amendment, which is attached as Exhibit 10.1 hereto and is incorporated herein by reference.

At the Annual Meeting, the Company’s stockholders also voted to approve Amendment No. 3 (the “2016 ESPP Amendment”) to the Amended and Restated 2013 Employee Stock Purchase Plan, as amended and restated on June 27, 2016 (the “2016 ESPP”). The 2016 ESPP Amendment increases the number of shares of the Company’s common stock authorized for issuance under the 2016 ESPP by 300,000 shares to 1,700,000 shares. The foregoing summary of the 2016 ESPP Amendment is qualified in its entirety by reference to the full text of the 2016 ESPP Amendment, which is attached as Exhibit 10.2 hereto and is incorporated herein by reference.